Our mission
No woman should die whilst bringing a new life into the world. Every baby, every child deserves a healthy start in life.
This is the reason our scientists come to work, the reason our service engineers answer calls on weekends, and the reason we've spent 40 years making sure the science gets to the people who need it.
Heritage
The Wallac story: Where it all began
In 1985, a small team of scientists at Wallac in Turku, Finland, set out to develop one of the world's first automated screening systems - the beginning of a legacy that would quietly change the lives of millions.
Today, Revvity's screening solutions are used across the globe. But the pioneering spirit of those early Wallac innovators still guides everything we do.
Meet the people behind the science
Together, they've shaped 40 years of screening innovation. In their own words, meet the leaders, the experts, and the innovators who have made Revvity's work in newborn and prenatal screening possible.
Hear from Anna Godenhjelm, VP & GM, Reproductive Health, on 40 years of progress and what's next.
Read the full interviews
Real stories, real results
Behind every screening result is a family, a clinician, a lab, real people whose lives have been changed by the work we do. Hear from the families whose stories remind us why this work matters, and from the partners who've experienced Revvity's commitment firsthand.
40 years of screening innovation
Four decades of milestones, breakthroughs, and firsts. Explore the key moments that have shaped early detection and intervention as we know it today.
The scale of our reach. The depth of our impact.
33M
babies screened annually by Revvity screening systems
9M+
pregnancies screened for trisomies every year
115+
countries served by Revvity
Screening programs: reaching more families worldwide
Some of our most meaningful work has been supporting countries as they launch their very first newborn screening programs. From program design to ongoing partnership, Revvity has helped build screening programs from the ground up across the globe, so that more families, in more places, can benefit from early detection.
Our screening impact
Featured resources
For in vitro diagnostic use. This product is only available where licensed in accordance with the law. Please contact your local representative for availability.
Revvity Inc. does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations, please consult your local health care professionals.
Contact us
If you would like to speak to our experts, please click the button below to request more information.